These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16049639)

  • 21. Effect of parenteral l-alanyl-l-glutamine administration on phagocytic responses of polymorphonuclear neutrophilic leukocytes in dogs undergoing high-dose methylprednisolone sodium succinate treatment.
    Kang JH; Kim SS; Yang MP
    Am J Vet Res; 2012 Sep; 73(9):1410-7. PubMed ID: 22924723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy--a randomized crossover study.
    Li Y; Ping X; Yu B; Liu F; Ni X; Li J
    Aliment Pharmacol Ther; 2009 Sep; 30(5):452-8. PubMed ID: 19549287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral supplementation with glutamine and alanyl-glutamine on glutamine, glutamate, and glutathione status in trained rats and subjected to long-duration exercise.
    Cruzat VF; Tirapegui J
    Nutrition; 2009 Apr; 25(4):428-35. PubMed ID: 19056244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients.
    Berg A; Bellander BM; Wanecek M; Norberg A; Ungerstedt U; Rooyackers O; Wernerman J
    Clin Nutr; 2008 Dec; 27(6):816-21. PubMed ID: 18649974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of supplementation with free glutamine and the dipeptide alanyl-glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise.
    Cruzat VF; Rogero MM; Tirapegui J
    Cell Biochem Funct; 2010 Jan; 28(1):24-30. PubMed ID: 19885855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteral alanyl-glutamine supplement promotes intestinal adaptation in rats.
    Satoh J; Tsujikawa T; Fujiyama Y; Banba T
    Int J Mol Med; 2003 Oct; 12(4):615-20. PubMed ID: 12964044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress.
    Alves WF; Aguiar EE; Guimarães SB; da Silva Filho AR; Pinheiro PM; Soares Gdos S; de Vasconcelos PR
    Ann Vasc Surg; 2010 May; 24(4):461-7. PubMed ID: 20371164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury.
    Nägeli M; Fasshauer M; Sommerfeld J; Fendel A; Brandi G; Stover JF
    Crit Care; 2014 Jul; 18(4):R139. PubMed ID: 24992948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteral administration of alanyl-[2-(15)N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans.
    Ligthart-Melis GC; van de Poll MC; Vermeulen MA; Boelens PG; van den Tol MP; van Schaik C; De Bandt JP; Deutz NE; Dejong CH; van Leeuwen PA
    Am J Clin Nutr; 2009 Jul; 90(1):95-105. PubMed ID: 19458019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of alanyl-glutamine supplementation on plasma and tissue glutamine concentrations in rats submitted to exhaustive exercise.
    Rogero MM; Tirapegui J; Pedrosa RG; Castro IA; Pires IS
    Nutrition; 2006 May; 22(5):564-71. PubMed ID: 16472983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral nutrition with an amino acid solution containing a mixture of dipeptides. Evidence for efficient utilization of dipeptides in man.
    Brandl M; Sailer D; Langer K; Engelhardt A; Kleinhenz H; Adibi SA; Fekl W
    Beitr Infusionther Klin Ernahr; 1987; 17():103-16. PubMed ID: 3120689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure.
    Druml W; Hübl W; Roth E; Lochs H
    Hepatology; 1995 Apr; 21(4):923-8. PubMed ID: 7705801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever.
    Klassen P; Mazariegos M; Solomons NW; Fürst P
    J Nutr; 2000 Feb; 130(2):177-82. PubMed ID: 10720166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
    van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
    Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal and plasma amino acid concentrations after administration of i.v. glycyl-glutamine and glycyl-tyrosine containing amino acid solutions in humans.
    Himmelseher S; Pfenninger E; Herrmann P
    JPEN J Parenter Enteral Nutr; 1996; 20(4):281-6. PubMed ID: 8865110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal renal metabolism of L-citrulline and L-arginine following enteral or parenteral infusion of L-alanyl-L-[2,15N]glutamine or L-[2,15N]glutamine in mice.
    Boelens PG; van Leeuwen PA; Dejong CH; Deutz NE
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G679-85. PubMed ID: 15933220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of intravenous glutamine supplementation in trauma ICU patients.
    Pérez-Bárcena J; Marsé P; Zabalegui-Pérez A; Corral E; Herrán-Monge R; Gero-Escapa M; Cervera M; Llompart-Pou JA; Ayestarán I; Raurich JM; Oliver A; Buño A; García de Lorenzo A; Frontera G
    Intensive Care Med; 2014 Apr; 40(4):539-47. PubMed ID: 24556911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability of glutamine supplied intravenously as alanylglutamine.
    Fürst P; Albers S; Stehle P
    Metabolism; 1989 Aug; 38(8 Suppl 1):67-72. PubMed ID: 2668705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-alanyl-L-tyrosine as a tyrosine source during total parenteral nutrition. Infusion at 0.5 and 2 mmoles/kg/day in adult rats.
    Daabees TT; Stegink LD
    Pediatr Res; 1979 Aug; 13(8):894-9. PubMed ID: 113768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass.
    Lomivorotov VV; Efremov SM; Shmirev VA; Ponomarev DN; Lomivorotov VN; Karaskov AM
    Heart Surg Forum; 2011 Dec; 14(6):E384-8. PubMed ID: 22167767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.